Publications
  1. ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors

    Berns, K., Caumanns, J. J., Hijmans, E. M., Gennissen, A. M. C., Severson, T. M., Evers, B., Wisman, G. B. A., Jan Meersma, G., Lieftink, C., Beijersbergen, R. L., Itamochi, H., van der Zee, A. G. J., de Jong, S. & Bernards, R. 16-Aug-2018 In : ONCOGENE. 37, 33, p. 4611-4625 15 p.

    Research output: Contribution to journalArticle

  2. Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma

    Caumanns, J. J., Berns, K., Wisman, G. B. A., Fehrmann, R. S. N., Tomar, T., Klip, H., Meersma, G. J., Hijmans, E. M., Gennissen, A., Duiker, E. W., Weening, D., Itamochi, H., Kluin, R. J., Reyners, A. K. L., Birrer, M. J., Salvesen, H. B., Vergote, I., Van Nieuwenhuysen, E., Brenton, J. D., Braicu, E. I., Kupryjanczyk, J., Spiewankiewicz, B., Mittempergher, L., Bernards, R., van der Zee, A. G. J. & de Jong, S. 15-Aug-2018 In : Clinical Cancer Research. 24, 16, p. 3928-3940 13 p.

    Research output: Contribution to journalArticle

  3. Heart Failure Stimulates Tumor Growth by Circulating Factors

    Meijers, W. C., Maglione, M., Bakker, S. J. L., Oberhuber, R., Kieneker, L. M., de Jong, S., Haubner, B. J., Nagengast, W. B., Lyon, A. R., van der Vegt, B., van Veldhuisen, D. J., Westenbrink, B. D., van der Meer, P., Silljé, H. H. W. & de Boer, R. A. 14-Aug-2018 In : Circulation. 138, 7, p. 678-691 14 p.

    Research output: Contribution to journalArticle

View all (169) »

Activities
  1. European Society of Gynecological Oncology (External organisation)

    Jong, de, S. (Member)
    2011 → …

    Activity: ProfessionalMembership of network

View all (1) »

View graph of relations

ID: 94427